This inventor holds 5 USPTO granted patents and 6 published patent applications and 1 EPO patent. Top assignees: Pliant Therapeutics, Inc., Theravance Biopharma R&d IP, LLC. Active years: 2022-2024.
Company Filing History:
Years Active: 2022-2024
Title: The Innovative Journey of Christopher Bailey
Introduction
Christopher Bailey, an accomplished inventor based in Mountain View, CA, has made significant contributions to the field of biomedical science through his innovative inventions. With a total of five patents to his name, his work focuses primarily on the development of compounds that serve as inhibitors for certain integrins, which play a crucial role in various fibrotic diseases.
Latest Patents
Bailey's latest patents include groundbreaking inventions such as "Substituted amino acids as integrin inhibitors." This invention pertains to compounds that are useful for treating fibrosis conditions, including nonalcoholic steatohepatitis (NASH), idiopathic pulmonary fibrosis (IPF), and nonspecific interstitial pneumonia (NSIP). In addition, he has developed "Amino acid compounds with unbranched linkers and methods of use." These compounds serve as inhibitors for αβintegrin and also target idiopathic pulmonary fibrosis (IPF) and nonspecific interstitial pneumonia (NSIP).
Career Highlights
Throughout his career, Christopher Bailey has been associated with reputable companies where his innovative thinking and expertise have flourished. Notably, he has worked with Pliant Therapeutics, Inc. and Theravance Biopharma R&D IP, LLC. His efforts have resulted in significant advancements in pharmaceutical compositions aimed at combating complex fibrotic illnesses.
Collaborations
Bailey's collaborative efforts with industry professionals have further propelled his inventions into the limelight. Among his notable coworkers are Jacob Cha and Katerina Leftheris, with whom he has shared insights and expertise in research and development.
Conclusion
Christopher Bailey exemplifies the spirit of innovation through his prolific inventions and patents. His work not only contributes to the scientific community but also holds immense potential for improving patient outcomes in various fibrotic diseases. As he continues to push the boundaries of biotechnology, Bailey's contributions will likely pave the way for future breakthroughs in medicine.